Register for updates

 
 

Biology & Evolution
RSS Feed
TAU Scientist Prof. Judith Berman Is Elected Member of European Molecular Biology Organization
Thursday, June 27, 2019 9:00:00 AM

EMBO promotes excellence in the life sciences in Europe and beyond

Tel Aviv University's Prof. Judith Berman was recently named one of 56 new members of the European Molecular Biology Organization (EMBO), a group of more than 1,800 of the most prestigious researchers in Europe and around the world.

Prof. Berman of TAU's George S. Wise Faculty of Life Sciences is being recognized for her outstanding achievements in the study of the growth and evolution of yeast. A fellow of the American Association for the Advancement of Science (AAAS) and the American Society for Microbiology, she uses yeasts, especially pathogenic yeasts, to address basic mechanisms of genome change that underlie rapid phenotypic responses to stress.

"We are proud of Prof. Berman for being elected to EMBO, which chooses only the most exceptional scientists to join its ranks," says Prof. Karen Avraham, vice dean of TAU's Sackler Faculty of Medicine, a member of the EMBO Council and Prof. Berman's nominator for EMBO.

"Prof. Berman is a highly appreciated member of the Faculty of Life Sciences at TAU," says Prof. Abdussalam Azem, dean of the Wise Faculty. "Prof. Berman's election to EMBO is a strong recognition of her research, which is at the forefront of molecular biology of pathogenic yeasts."

EMBO members actively participate in the execution of the organization's initiatives by sitting on committees and editorial boards, evaluating applications for EMBO funding, mentoring young scientists and providing suggestions and feedback on activities. They conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution.

"It is a great honor to be recognized for my study of pathogenic yeasts of humans and their responses to antifungal drug stress," Prof. Berman says. "These include mitotic defects that cause aneuploidy and cell-to-cell heterogeneity driven by non-genetic mechanisms. We investigate the interplay between chromosome instability, membrane and cell wall dynamics, and intracellular localization of antifungal drugs to better understand processes that modulate the amplitude and diversity of phenotypic responses."

EMBO will formally welcome its new members and associate members October 29-31 at the Annual Members' Meeting in Heidelberg.




Latest News

Business and Civic Leader Mort Mandel Awarded TAU Honorary Doctorate

Mr. Mandel cited for his visionary philanthropy and establishment of the Jack, Joseph and Morton Mandel Center for STEM and the Humanities at TAU.

Early Humans Used Tiny, Flint "Surgical" Tools to Butcher Elephants

New discovery by TAU-led research group suggests early humans in the Levant were sophisticated and environmentally conscious.

TAU Ranks Among Top 10 Undergraduate Programs Producing Most Venture Capital-Backed Entrepreneurs

Joining Stanford, UC Berkeley, and MIT, TAU is the only non-U.S. university to make top 10 of global VC list.

Protein Mapping Pinpoints Why Most Metastatic Melanoma Patients Do Not Respond to Immunotherapy

Lipid metabolism found to affect cancer cells' visibility to the immune system, say TAU, Sheba Medical Center researchers.

Breakdown in Coral Spawning Places Species at Risk of Extinction

Synchronized coral spawning has become erratic, endangering the long-term survival of coral species, TAU researchers say.

Joanna Naftali Named Associate Vice President, Midwest of AFTAU

Accomplished fundraiser has deep roots in educational, philanthropic, and arts sectors.

Blocking Inflammatory Pathway Key to Preventing Brain Metastasis from Melanoma

Tumor cells "hijack" their way to the brain through an inflammatory factor secreted by brain cells, say TAU researchers.

TAU and Technion Researchers Wrest Control of One of World's Most Secure PLCs

Rogue engineering station instigated "hostile intervention" of Siemens programmable logic controller that runs industrial processes.

Novel Immunotherapy May Prevent Brain Metastases

Injection of synthetic DNA material found to activate brain's immune cells and kill invading tumor cells, TAU researchers say.

TAU Scientists Develop Novel Nano-Vaccine for Melanoma

Injection of nanoparticle has proven effective in mouse models, researchers say.

contentSecondary
c

© 2019 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University